| Literature DB >> 35263574 |
Jocelyn G Labombarde1, Meenu R Pillai1, Marie Wehenkel1, Chun-Yang Lin2, Rachael Keating1, Scott A Brown1, Jeremy Chase Crawford1, David C Brice1, Ashley H Castellaw1, Alexandra H Mandarano1, Clifford S Guy1, Juan R Mejia1, Carlessia D Lewis1, Ti-Cheng Chang3, Christine M Oshansky1, Sook-San Wong4, Richard J Webby4, Mei Yan5, Quan-Zhen Li5, Tony N Marion6, Paul G Thomas1, Maureen A McGargill7.
Abstract
Infection and vaccination repeatedly expose individuals to antigens that are conserved between influenza virus subtypes. Nevertheless, antibodies recognizing variable influenza epitopes greatly outnumber antibodies reactive against conserved epitopes. Elucidating factors contributing to the paucity of broadly reactive influenza antibodies remains a major obstacle for developing a universal influenza vaccine. Here, we report that inducing broadly reactive influenza antibodies increases autoreactive antibodies in humans and mice and exacerbates disease in four distinct models of autoimmune disease. Importantly, transferring broadly reactive influenza antibodies augments disease in the presence of inflammation or autoimmune susceptibility. Further, broadly reactive influenza antibodies spontaneously arise in mice with defects in B cell tolerance. Together, these data suggest that self-tolerance mechanisms limit the prevalence of broadly reactive influenza antibodies, which can exacerbate disease in the context of additional risk factors.Entities:
Keywords: antibody; autoimmunity; influenza; universal influenza vaccine
Mesh:
Substances:
Year: 2022 PMID: 35263574 PMCID: PMC9036619 DOI: 10.1016/j.celrep.2022.110482
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995